Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society
|
December 20, 2013
Cochrane Stroke Group: twenty years of evidence-based stroke medicine
E Berge, P Langhorne,
The Cochrane Database of Systematic Reviews
|
January 10, 2003
Anticoagulants versus antiplatelet agents for acute ischaemic stroke
E Berge, P Sandercock
Clinical Genetics
|
June 18, 1998
Polymorphisms at the angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure
K E Berge, K Berg
Clinical Genetics
|
September 1, 1991
A TaqI RFLP at the human renal kallikrein (KLK1) locus
K E Berge, K Berg
Nucleic Acids Research
|
October 25, 1990
A TaqI RFLP at the EDN1 gene locus
K E Berge, K Berg
Clinical Genetics
|
April 1, 1994
No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability
K E Berge, K Berg
Clinical Genetics
|
March 31, 1998
Cardiovascular risk factors in people with different genotypes in the insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE)
K E Berge, K Berg
Clinical Genetics
|
February 1, 1992
No effect of a Taq1 polymorphism in DNA at the endothelin I (EDN1) locus on normal blood pressure level or variability
K E Berge, K Berg
Lancet (London, England)
|
April 11, 2001
Heparin and aspirin in stroke
E Berge, P M Sandset
Clinical Genetics
|
December 1, 1994
No effect on blood pressure level or variability of polymorphisms in DNA at the locus for atrial natriuretic factor (ANF)
K E Berge, K Berg
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
International Journal of Stroke : Official Journal of the International Stroke Society
|
December 20, 2013
Cochrane Stroke Group: twenty years of evidence-based stroke medicine
E Berge, P Langhorne,
The Cochrane Database of Systematic Reviews
|
January 10, 2003
Anticoagulants versus antiplatelet agents for acute ischaemic stroke
E Berge, P Sandercock
Clinical Genetics
|
June 18, 1998
Polymorphisms at the angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure
K E Berge, K Berg
Clinical Genetics
|
September 1, 1991
A TaqI RFLP at the human renal kallikrein (KLK1) locus
K E Berge, K Berg
Nucleic Acids Research
|
October 25, 1990
A TaqI RFLP at the EDN1 gene locus
K E Berge, K Berg
Clinical Genetics
|
April 1, 1994
No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability
K E Berge, K Berg
Clinical Genetics
|
March 31, 1998
Cardiovascular risk factors in people with different genotypes in the insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE)
K E Berge, K Berg
Clinical Genetics
|
February 1, 1992
No effect of a Taq1 polymorphism in DNA at the endothelin I (EDN1) locus on normal blood pressure level or variability
K E Berge, K Berg
Lancet (London, England)
|
April 11, 2001
Heparin and aspirin in stroke
E Berge, P M Sandset
Clinical Genetics
|
December 1, 1994
No effect on blood pressure level or variability of polymorphisms in DNA at the locus for atrial natriuretic factor (ANF)
K E Berge, K Berg
Page
of 10